25.03.2014 • News

Merck KGaA Signs Contract for Anti-Aging Ingredient

German chemical and pharmaceutical producer Merck KGaA has signed an exclusive agreement with Laboratory Skin Care to market the U.S. company's cosmetic active ingredient Hydroxysomes Calcium.

Under the agreement, Merck will market the ingredient globally under the co-brand name Ronacare Hydroxysomes Calcium, starting from October of this year.

The product is said to accelerate skin regeneration by transporting the mineral into deeper skin layers several folds more effectively than conventional alternatives.

"Hydroxysomes Calcium fits perfectly within our expanding portfolio for providing our customers with anti-active ingredients that are technologically sophisticated, patent-protected and globally approved," said Michael Weiden, head of Functional Materials within Merck's Pigments & Cosmetics business unit.

Zari Mansouri, CEO of California-based Laboratory Skin Care, added that, beyond the benefit of being able to tap the German partner's sales channels, "we're confident that the two brands, Hydroxysomes and Ronacare, will optimally complement each other."

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.